Table 2.

Oxidative stress markers among ART-treated versus ART naïve patients

Parameter	HIV (ART-treated)*	HIV (ART-naïve)*	P-value (statistical power)
Vitamin C(mg/dl)Median(IQR)	0.1(0.09–0.19)	0.28(0.12–0.18)	0.001 (100)
Albumin(g/l) Median(IQR)	33.3(26.3–42.70)	27.50(19.70–31.30)	0.001 (100)
TP(mg/ml) Median(IQR)	43.8(39.5–45.40)	42.90(40–45.30)	0.66 (68)
TAS(mmol/l) Median(IQR)	1.3(1.00–1.89)	1.58(1.03–2.22)	0.43 (99.8)
MDA(µM) Median(IQR)	1.7(1.46–1.96)	1.73(1.56–1.86)	0.88 (83.4)
ALT(IU) Median(IQR)	9.9(5.9–17.5)	8.65(5.75–12.70)	0.32 (100)
AST(IU) Median(IQR)	36.7(21.5–57.00)	29.70(21.50–55.35)	0.70 (37.5)
GGT(IU) Median(IQR)	77.0(48.00–161)	53(30–80.50)	0.02 (100)

Abbreviations: TP= Total protein, TAS=Total antioxidant status, MDA=Malondialdehyde, ALT=Alanine transaminase, AST=Aspartate transaminase, GGT=Gamma glutamyl transpeptidase. Legend:

^*Includes both HIV-mono infected and HIV/TB co-infected patients